118 related articles for article (PubMed ID: 34714793)
1. A Competing Risk-based Prognostic Model to Predict Cancer-specific Death of Patients with Spinal and Pelvic Chondrosarcoma.
Dong Y; Xie L; Kang H; Peng R; Guo Q; Song K; Wang J; Guan H; Fang Z; Li F
Spine (Phila Pa 1976); 2021 Nov; 46(22):E1192-E1201. PubMed ID: 34714793
[TBL] [Abstract][Full Text] [Related]
2. Competing risk nomogram for predicting prognosis of patients with spinal and pelvic chordoma: A SEER-based retrospective study.
Li J; Ma C; Yuan X; Li N; Xu Y; Guo J; Liao H
Eur Spine J; 2023 Apr; 32(4):1334-1344. PubMed ID: 36805321
[TBL] [Abstract][Full Text] [Related]
3. Can a Nomogram Help to Predict the Overall and Cancer-specific Survival of Patients With Chondrosarcoma?
Song K; Shi X; Wang H; Zou F; Lu F; Ma X; Xia X; Jiang J
Clin Orthop Relat Res; 2018 May; 476(5):987-996. PubMed ID: 29470233
[TBL] [Abstract][Full Text] [Related]
4. Development and Validation of Nomograms Predicting Overall and Cancer-Specific Survival of Spinal Chondrosarcoma Patients.
Song K; Song J; Shi X; Wang H; Ma X; Xia X; Liang X; Lin K; Jiang J
Spine (Phila Pa 1976); 2018 Nov; 43(21):E1281-E1289. PubMed ID: 29664813
[TBL] [Abstract][Full Text] [Related]
5. A competing-risk nomogram to predict cause-specific death in elderly patients with colorectal cancer after surgery (especially for colon cancer).
Wang Z; Wang Y; Yang Y; Luo Y; Liu J; Xu Y; Liu X
World J Surg Oncol; 2020 Feb; 18(1):30. PubMed ID: 32019568
[TBL] [Abstract][Full Text] [Related]
6. Development and external validation of nomograms to predict sarcoma-specific death and disease progression after surgical resection of localized high-grade conventional primary central chondrosarcoma and dedifferentiated chondrosarcoma.
Tsuda Y; Tsoi K; Stevenson JD; Laitinen M; Ferguson PC; Wunder JS; Griffin AM; van de Sande MAJ; van Praag V; Leithner A; Fujiwara T; Yasunaga H; Matsui H; Parry MC; Jeys LM
Bone Joint J; 2020 Dec; 102-B(12):1752-1759. PubMed ID: 33249892
[TBL] [Abstract][Full Text] [Related]
7. A novel model to predict cancer-specific survival in patients with early-stage uterine papillary serous carcinoma (UPSC).
Chen L; Liu X; Li M; Wang S; Zhou H; Liu L; Cheng X
Cancer Med; 2020 Feb; 9(3):988-998. PubMed ID: 31846222
[TBL] [Abstract][Full Text] [Related]
8. Risk analysis of pulmonary metastasis of chondrosarcoma by establishing and validating a new clinical prediction model: a clinical study based on SEER database.
Li W; Dong S; Wang H; Wu R; Wu H; Tang ZR; Zhang J; Hu Z; Yin C
BMC Musculoskelet Disord; 2021 Jun; 22(1):529. PubMed ID: 34107945
[TBL] [Abstract][Full Text] [Related]
9. Identifying the Prognosis Factors and Predicting the Survival Probability in Patients with Non-Metastatic Chondrosarcoma from the SEER Database.
Huang R; Sun Z; Zheng H; Yan P; Hu P; Yin H; Zhang J; Meng T; Huang Z
Orthop Surg; 2019 Oct; 11(5):801-810. PubMed ID: 31663279
[TBL] [Abstract][Full Text] [Related]
10. Prognostic nomograms to predict overall survival and cancer-specific survival in patients with pelvic chondrosarcoma.
Chen L; Long C; Liu J; Duan X; Xiang Z
Cancer Med; 2019 Sep; 8(12):5438-5449. PubMed ID: 31353800
[TBL] [Abstract][Full Text] [Related]
11. A Nomogram and a Risk Classification System Predicting the Cancer-Specific Survival of Patients With Initially-Diagnosed Osseous Spinal and Pelvic Tumors.
Zhou Q; Li AB; Lin ZQ; Zhang HZ
Spine (Phila Pa 1976); 2020 Jun; 45(12):E713-E720. PubMed ID: 32039945
[TBL] [Abstract][Full Text] [Related]
12. A Novel Nomogram and Risk Classification System Predicting the Cancer-Specific Mortality of Patients with Initially Diagnosed Metastatic Cutaneous Melanoma.
Li W; Xiao Y; Xu X; Zhang Y
Ann Surg Oncol; 2021 Jul; 28(7):3490-3500. PubMed ID: 33191484
[TBL] [Abstract][Full Text] [Related]
13. Competing risk nomogram predicting cancer-specific mortality for endometrial cancer patients treated with hysterectomy.
Xie G; Qi C; Yang W; Wang R; Yang L; Shang L; Huang L; Chung MC
Cancer Med; 2021 May; 10(10):3205-3213. PubMed ID: 33932121
[TBL] [Abstract][Full Text] [Related]
14. Nomograms for Differentiated Thyroid Carcinoma Patients Based on the Eighth AJCC Staging and Competing Risks Model.
Li C; Xu F; Huang Q; Han D; Zheng S; Wu W; Zhao F; Feng X; Lyu J
JNCI Cancer Spectr; 2021 Jun; 5(3):. PubMed ID: 34159295
[TBL] [Abstract][Full Text] [Related]
15. Competing-risks nomogram for predicting cancer-specific death in upper tract urothelial carcinoma: a population-based analysis.
Li C; Han D; Huang Q; Xu F; Zheng S; Li X; Zhao F; Feng X; Lyu J
BMJ Open; 2021 Jul; 11(7):e048243. PubMed ID: 34281927
[TBL] [Abstract][Full Text] [Related]
16. Developing and validating a novel nomogram used a competing-risks model for predicting the prognosis of primary fallopian tube carcinoma: a retrospective study based on the SEER database.
Li C; Li J; Huang Q; Feng X; Zhao F; Xu F; Han D; Lyu J
Ann Transl Med; 2021 Mar; 9(5):378. PubMed ID: 33842599
[TBL] [Abstract][Full Text] [Related]
17. Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis.
Callegaro D; Miceli R; Bonvalot S; Ferguson P; Strauss DC; Levy A; Griffin A; Hayes AJ; Stacchiotti S; Pechoux CL; Smith MJ; Fiore M; Dei Tos AP; Smith HG; Mariani L; Wunder JS; Pollock RE; Casali PG; Gronchi A
Lancet Oncol; 2016 May; 17(5):671-80. PubMed ID: 27068860
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a nomogram containing the prognostic determinants of chondrosarcoma based on the Surveillance, Epidemiology, and End Results database.
Zhang J; Pan Z; Zhao F; Feng X; Huang Y; Hu C; Li Y; Lyu J
Int J Clin Oncol; 2019 Nov; 24(11):1459-1467. PubMed ID: 31243629
[TBL] [Abstract][Full Text] [Related]
19. Competing risk nomogram predicting initial loco-regional recurrence in gastric cancer patients after D2 gastrectomy.
Wang SB; Qi WX; Chen JY; Xu C; Kirova YM; Cao WG; Cai R; Cao L; Yan M; Cai G
Radiat Oncol; 2019 Jul; 14(1):128. PubMed ID: 31315683
[TBL] [Abstract][Full Text] [Related]
20. A competing risk nomogram for predicting cancer-specific death of patients with buccal mucosa cancer.
Jiang Q; Xue D; Xin Y; Qiu J
Oral Dis; 2021 May; 27(4):900-910. PubMed ID: 32791562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
